Susquehanna Fundamental Investments’s Pfizer PFE Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,301,772	Closed	-$34.5M	–	1193
2024 Q4	$34.5M	Buy	+1,301,772	New	+$35.3M	0.49%	26
2024 Q2	$37.1M	Sell	1,325,937 -141,170	-10%	-$3.89M	0.86%	10
2024 Q1	$40.7M	Buy	+1,467,107	New	+$40.7M	1.9%	3
2022 Q1	$1.53M	Sell	29,620 -381,800	-93%	-$19.8M	0.03%	687
2021 Q4	$24.3M	Hold	411,420	–	–	0.64%	14
2021 Q3	$17.7M	Sell	411,420 -7,600	-2%	-$337K	0.33%	56
2021 Q2	$16.4M	Sell	419,020 -232,390	-36%	-$9.04M	0.3%	61
2021 Q1	$23.6M	Buy	651,410 +116,075	+22%	+$4.12M	0.4%	32
2020 Q4	$19.7M	Buy	535,335 +91,866	+21%	+$3.37M	0.36%	41
2020 Q3	$15.4M	Buy	443,469 +164,791	+59%	+$5.78M	0.46%	17
2020 Q2	$8.65M	Buy	+278,678	New	+$9.47M	0.41%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna Fundamental Investments's PFE Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of Pfizer (PFE) in Q1 2025, closing a stake of 1,301,772 shares — an estimated $34.5M sold.

Susquehanna Fundamental Investments first reported a position in PFE in Q2 2020 and held it in 11 quarters. The position peaked at $40.7M in Q1 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Susquehanna Fundamental Investments reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 1,301,772 Pfizer shares in Q1 2025, an estimated $34.5M.
Susquehanna Fundamental Investments first reported a position in Pfizer in Q2 2020 and held it in 11 quarters.
Susquehanna Fundamental Investments's Pfizer position peaked at $40.7M in Q1 2024.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.